company background image
QLINEA logo

Q-linea OM:QLINEA Stock Report

Last Price

SEK 0.38

Market Cap

SEK 1.6b

7D

16.4%

1Y

-84.6%

Updated

09 Feb, 2025

Data

Company Financials +

QLINEA Stock Overview

Engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. More details

QLINEA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health1/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Q-linea AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Q-linea
Historical stock prices
Current Share PriceSEK 0.38
52 Week HighSEK 5.60
52 Week LowSEK 0.10
Beta0.97
1 Month Change-8.46%
3 Month Change-74.33%
1 Year Change-84.58%
3 Year Change-99.59%
5 Year Change-99.46%
Change since IPO-99.43%

Recent News & Updates

Recent updates

Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Dec 31
Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

May 07
Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

Jan 11
Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

Shareholder Returns

QLINEASE Medical EquipmentSE Market
7D16.4%-1.3%-0.8%
1Y-84.6%-0.7%13.0%

Return vs Industry: QLINEA underperformed the Swedish Medical Equipment industry which returned -0.7% over the past year.

Return vs Market: QLINEA underperformed the Swedish Market which returned 13% over the past year.

Price Volatility

Is QLINEA's price volatile compared to industry and market?
QLINEA volatility
QLINEA Average Weekly Movement91.8%
Medical Equipment Industry Average Movement7.5%
Market Average Movement5.6%
10% most volatile stocks in SE Market12.2%
10% least volatile stocks in SE Market3.2%

Stable Share Price: QLINEA's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: QLINEA's weekly volatility has increased from 47% to 92% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200797Stuart Ganderqlinea.com

Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. The company offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. It serves healthcare providers.

Q-linea AB (publ) Fundamentals Summary

How do Q-linea's earnings and revenue compare to its market cap?
QLINEA fundamental statistics
Market capSEK 1.61b
Earnings (TTM)-SEK 218.33m
Revenue (TTM)SEK 3.50m

460.0x

P/S Ratio

-7.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QLINEA income statement (TTM)
RevenueSEK 3.50m
Cost of RevenueSEK 5.08m
Gross Profit-SEK 1.58m
Other ExpensesSEK 216.75m
Earnings-SEK 218.33m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 13, 2025

Earnings per share (EPS)-0.052
Gross Margin-45.21%
Net Profit Margin-6,243.44%
Debt/Equity Ratio305.9%

How did QLINEA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/09 01:11
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Q-linea AB (publ) is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Ulrik TrattnerCarnegie Investment Bank AB
Alexandru CogutKempen & Co. NV